TGFB1 and familial mitral valve prolapse: A pivotal role in the etiopathogenesis of the myxomatous phenotype of MVP is played by altered transforming growth factor-β (TGF-β) signaling pathway, that can however be somehow limited with the help of angiotensin-II inhibitors (5, 7, 8).